Investment Newsletters

H.C. Wainwright

H.C. Wainwright Weighs in on Advaxis, Inc (ADXS) Following Commercial Deal with Amgen (AMGN)

Analyst Swayampakula Ramakanth of H.C.

Zach Wohlberg — August 3, 2016, 3:35 PM EDT

H.C. Wainwright Weighs In on Agenus Inc (AGEN) Following 2Q:16 Update

In a research report released Friday, H.C.

Jason Cohen — July 29, 2016, 7:52 AM EDT

H.C. Wainwright Weighs In On Two Healthcare Stocks: Relypsa Inc (RLYP) and Biogen Inc (BIIB)

Relypsa Inc Yesterday, Relypsa Inc (NASDAQ:RLYP) announced that Galenica and Relypsa have entered into a definitive agreement under which Galenica will acquire Relypsa. …

Jason Cohen — July 22, 2016, 8:04 AM EDT

H.C. Wainwright Analyst Assumes Coverage on Vical Incorporated (VICL), Issues Buy

H.C.

Ben Kriegsman — July 19, 2016, 10:35 AM EDT

H.C. Wainwright Analyst Assumes Pluristem Therapeutics (PSTI), Affirms Buy.

H.C.

Ben Kriegsman — July 19, 2016, 10:29 AM EDT

H.C. Wainwright Analyst Pounds the Table on AEterna Zentaris Inc. (USA)

H.C.

Jason Cohen — July 11, 2016, 1:55 PM EDT

Healthcare Analysts Weigh In on Advaxis, Inc. (ADXS) and Insmed Incorporated (INSM) Following ASCO Presentation and Withdrawal of MAA Application

Advaxis, Inc. In a research report released today, H.

Jason Cohen — June 9, 2016, 3:27 PM EDT

H.C. Wainwright Maintains Buy On BioCryst Pharmaceuticals, Inc. (BCRX) Following 1Q:16 Update

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares slipped yesterday 9% after the drug discovery company reported first-quarter results and update on its clinical progress.

Jason Cohen — May 6, 2016, 7:53 AM EDT